drugset / Trial / NCT03484754

Infiltrations of OnaBotulinum Toxin A in Resistant Depression: Comparison of Two Facial Injection Sites.

NCT03484754 ↗

Unknown 58 enrolled Centre Hospitalier Esquirol
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to evaluate in adult subjects with resistant depression the effect of an injection of botulinum toxin in the corrugator and procerus muscles, in comparison to the infiltration of the crow's feet area, in addition to the current antidepressant treatment.

Timeline

Start
2018-04-01
Primary completion
2021-07-30
Completion
2021-12-31

Outcome

Met primary endpoint

paper 13 responders out of 29 patients (44.8%) in the glabella group and five out of 28 patients (17.9%) in the crow's feet group (p=0.029). PMID 40226647 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 10 iu Other